Pascal Longlade
Corporate Officer/Principal chez Roche Diagnostics GmbH
Profil
Pascal Longlade is currently working as a Project Manager-Cardiovascular at Roche Diagnostics GmbH.
Previously, he worked as a Director-Medical Affairs at Debregeas & Associes Pharma SAS, Director-Clinical Affairs at Abbott Vascular Devices, Chief Medical Officer at Trophos SA, and Chief Medical Officer at Kuros Biosciences Ltd.
He holds a doctorate degree from Faculté de Médecine Paris.
Postes actifs de Pascal Longlade
| Sociétés | Poste | Début |
|---|---|---|
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the private company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Corporate Officer/Principal | - |
Anciens postes connus de Pascal Longlade
| Sociétés | Poste | Fin |
|---|---|---|
Debregeas & Associes Pharma SAS
 Debregeas & Associes Pharma SAS Medical SpecialtiesHealth Technology Debregeas & Associes Pharma SAS is an independent, privately owned French specialty pharmaceutical company founded in 2006 by Patrice Debrégeas. The company is based in Paris, France. The company promotes agility, flexibility, and efficiency in their projects and encourages their teams to think outside the box. Taking risks is part of their DNA. | Chief Tech/Sci/R&D Officer | - |
Abbott Vascular Devices
 Abbott Vascular Devices Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Abbott Vascular Devices develops and manufactures cardiovascular devices for people with cardiovascular disease. The private company is based in Redwood City, CA. | Corporate Officer/Principal | - |
| KUROS BIOSCIENCES AG | Chief Tech/Sci/R&D Officer | - |
Trophos SA
 Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Chief Tech/Sci/R&D Officer | - |
Formation de Pascal Longlade
| Faculté de Médecine Paris | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KUROS BIOSCIENCES AG | Health Technology |
| Entreprise privées | 4 |
|---|---|
Debregeas & Associes Pharma SAS
Debregeas & Associes Pharma SAS Medical SpecialtiesHealth Technology Debregeas & Associes Pharma SAS is an independent, privately owned French specialty pharmaceutical company founded in 2006 by Patrice Debrégeas. The company is based in Paris, France. The company promotes agility, flexibility, and efficiency in their projects and encourages their teams to think outside the box. Taking risks is part of their DNA. | Health Technology |
Abbott Vascular Devices
Abbott Vascular Devices Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Abbott Vascular Devices develops and manufactures cardiovascular devices for people with cardiovascular disease. The private company is based in Redwood City, CA. | Health Technology |
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the private company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Commercial Services |
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Health Technology |
